Skip to main content

Social phobia

  • Chapter
  • 398 Accesses

Abstract

Social phobia (SP, also sometimes called social anxiety disorder) is common, impairing and responsive to treatment (Kessler et al., 1994, Schneier et al., 1994). It has also been termed “the neglected anxiety disorder” because it is often missed as a diagnosis (Liebowitz, 1999). A study showed that on subsequent administration of the SP section of the MINI questionnaire to patients who had presented with other psychiatric diagnoses, but had not been diagnosed by their physician as having SP, almost 25% met screening criteria for SP (Den Boer & Dunner, 1999). Therefore, physician recognition of SP remains suboptimal. Individuals with SP are 4 times more likely than the general population to develop other anxiety and mood disorders. They are also more likely to abuse alcohol and other substances. Social phobia is the most prevalent anxiety disorder and third most common psychiatric disorder in the US. However, this psychopathology is often underdiagnosed and a survey in Europe indicated that a diagnosis of phobia was made by general practitioners in only 24.2% of social phobics (Weiller et al., 1996). A recent, large-scale epidemiological study in the US showed that the 12-month prevalence rate of SP was 7.9% (6.6% for men, 9.1% for women) and 13.3% (11.1% for men, 15.5% for women) (Kessler et al., 1994). Another study which examined the prevalence of SP in the Swedish general population reported that the prevalence of this disorder was estimated at 15.6% but this prevalence rate varied between 1.9 and 20.4% across the different levels of distress and impairment that were used to define cases (Furmark et al., 1999).

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Albano AM, DiBartolo PM, Heimberg RG & Barlow DG. Children and adolescents: assessment and treatment. In: RG Heimberg, MR Liebowitz, DA Hope & FR Schnerer (eds): Social phobia: Diagnosis, assessments and treatment. New York, NY: Guildford Press, 387–425, 1995

    Google Scholar 

  • Angst J & Dobler-Mikola A. The Zurich Study: anxiety and phobia in young adults. Eur Arch Psychiatr Neurol Sci 235, 171–178, 1995

    Article  Google Scholar 

  • Allgulander C. Paroxetine in social anxiety disorder. A randomized placebo-controlled study. Acta Psychiatr Scand 99, 1–6, 1999

    Google Scholar 

  • Alnaes R & Torgersen S. The relationship between DSM-III symptom disorders (Axis I) and personality disorders (Axis II) in an outpatient population. Acta Psychiatr Scand 78, 485–492, 1988

    Article  PubMed  CAS  Google Scholar 

  • Altamura AC, Piolo R, Vitto M & Mannu P. Venlafaxine in social phobia: a study in selective serotonin reuptake inhibitor non-responders. Int Clin Psychopharmacol 14, 239–245, 1999

    Article  PubMed  CAS  Google Scholar 

  • Amies PL, Gelder MG & Shaw PM. Social phobia: a comparative clinical study. Br J Psychiatry 142, 174–179, 1983

    Article  PubMed  CAS  Google Scholar 

  • Amin N, Foa EB & Coles ME. Negative interpretation bias in social phobia. Behav Res Ther 36, 945–957, 1998

    Article  PubMed  CAS  Google Scholar 

  • Baldwin D, Bobes J, Stein DJ, Scharwächter I & Faure M. Paroxetine in social phobia/Social anxiety disorder. Br J Psychiatry 175, 120–126, 1999

    Article  PubMed  CAS  Google Scholar 

  • Ball SG, Otto MW, Pollack MH, Uccello R & Rosenbaum JF. Differentiating social phobia and panic disorder: a test of core beliefs. Cogn Ther Res 19, 473–481, 1995

    Article  Google Scholar 

  • Ballenger JC, Davidson JRT, Lecrubier Y, Nutt DJ, Bobes J, Beidel DC, Ono Y & Westenberg HGM. Consensus statement on social anxiety disorder from the International Consensus Group on depression and anxiety. J Clin Psychiatry 59 (17), 54–60, 1998

    PubMed  Google Scholar 

  • Beidel DC, Turner SM & Cooley MR. Assessing reliable and clinically significant change in social phobia: Validity of the Social Phobia and Anxiety Inventory. Behav Res Therapy 31, 331–337, 1993

    Article  CAS  Google Scholar 

  • Beidel DC & Turner SM. Shy children, phobic adults. The nature and treatment of social phobia. Washington DC. American Psychological Association, 1998

    Book  Google Scholar 

  • Bell CJ, Malizia AL & Nutt DJ. The neurobiology of social phobia. Eur Arch Psychiatry Clin Neurosci 249 (Suppl), S11–S18, 1999

    Article  PubMed  Google Scholar 

  • Bijl RV, Ravelli A & VanZessen G. Prevalence of psychiatric disorder in the general population: results of the Netherlands Mental Health Survey and Incidence Study (NEMESIS). Soc Psychiatr Epidemiol 33, 587–595, 1998

    Article  CAS  Google Scholar 

  • Bisserbe JC, Lépine J-P & the GRP Group. Moclobemide in social phobia: A pilot open study. Clin Neuropharmacol 17 (1), S88–S94, 1994

    Article  PubMed  Google Scholar 

  • Black B & Uhde TW. Psychiatric characteristics of children with selective mutism: a pilot study. J Am Acad Child Adolesc Psychiatry 34, 847–856, 1995

    Article  PubMed  CAS  Google Scholar 

  • Bobes J. How is recovery from social anxiety disorder defined? J Clin Psychiatry 59 (17), 12–16, 1998

    PubMed  Google Scholar 

  • Bouwer C & Stein DJ. Use of the selective serotonin reuptake inhibitor citalopram in the treatment of generalized social phobia. J Affect Disord 49, 79–82, 1998

    Article  PubMed  CAS  Google Scholar 

  • Brown EJ, Heimberg RG & Harlan RJ. Social phobia subtype and avoidant personality disorder: effect on severity of social phobia, impairment, and outcome of cognitive behavioral treatment. Behav Ther 26, 467–486, 1995

    Article  Google Scholar 

  • Butler G, Cullington A, Munby M, Amies P & Gelder M. Exposure and anxiety management in the treatment of social phobia. J Consult Clin Psychol 52 (4), 642–650, 1984

    Article  PubMed  CAS  Google Scholar 

  • Chambless DL, Cherney J, Caputo GC & Rheinstein BJG. Anxiety disorders and alcoholism:a study with inpatient alcoholics. J Anxiety Disord 1, 29–40, 1987

    Article  Google Scholar 

  • Chartier MJ, Hazen AL & Stein MB. Lifetime patterns of social phobia: A retrospective study of the course of social phobia in a nonclinical population. Depress Anxiety 7, 113–121, 1998

    Article  PubMed  CAS  Google Scholar 

  • Chakravorty SG & Halbreich U. The influence of estrogen on monoamine oxidase activity. Psychopharmacol Bull 33, 229–233, 1997

    PubMed  CAS  Google Scholar 

  • Clark DM & Wells A. A cognitive model of social phobia. In: RG Heimberg, MR Liebowitz, DA Hope et al (eds): Social phobia: Diagnosis, assessment, and treatment. New York, NY: Guildford Press, 69–93, 1995

    Google Scholar 

  • Clark DB & Agras WS. The assessment and treatment of performance anxiety in musicians. Am J Psychiatry 148, 598–605, 1991

    PubMed  CAS  Google Scholar 

  • Clark DB, Bukstein OG, Smith MG, Kaczynski NA, Mezzich AC & Donovan JE. Identifying anxiety disorders in adolescents hospitalized for alcohol abuse or dependence. Psychiatr Sery 46 (6), 618–620, 1995

    CAS  Google Scholar 

  • Clark DB, Turner S, Beidel D, Donovan J, Kirisci L & Jacob RG. Reliability and validity of the social phobia and anxiety inventory for adolescents. Psychol Assess 6, 135–140, 1994

    Article  Google Scholar 

  • Clarvit SR, Schneier FR & Liebowitz MR. The offensive subtype of Taijin-Kyofu-Sho in New York City: The phenomenology and treatment of a social anxiety disorder. J Clin Psychiatry 57, 523–527, 1996

    Article  PubMed  CAS  Google Scholar 

  • Daleiden EL & Vasey MW. An information-processing perspective on childhood anxiety. Clin Psychol Rev 17, 407–429, 1997

    Article  PubMed  CAS  Google Scholar 

  • Davidson JR, Hughes DL, George LK & Blazer DG. The epidemiology of social phobia: findings from the Duke Epidemiological Catchment Area Study. Psychol Med 23 (3), 709–718, 1993

    Article  PubMed  CAS  Google Scholar 

  • Davidson JR, Krishnan KR, Charles HC, Boyko O, Potts NL, Ford SM & Patterson L. Magnetic resonance spectroscopy in social phobia: preliminary findings. J Clin Psychiatry 54 Suppl, 19–25, 1993

    PubMed  Google Scholar 

  • Davidson JRT, Potts NLS, Richichi EA, Ford SM, Krishnan KRR, Smith RD & Wilson W. The brief social phobia scale. J Clin Psychiatry 52, 48–51, 1991

    PubMed  Google Scholar 

  • Degonda M & Angst J. The Zurich study. XX. Social phobia and agoraphobia. European Arch Psychiatry Clin Neurosci 243, 95–102, 1993

    Article  CAS  Google Scholar 

  • Deltito JA & Stam M. Psychopharmacological treatment of avoidant personality disorder. Compr Psychiatry 30, 498–504, 1989

    Article  PubMed  CAS  Google Scholar 

  • Den Boer JA & Dunner DL. Physician attitudes concerning diagnosis and treatment of social anxiety disorder in Europe and North America. Int J Psychiatry Clin Practice 3 (3), S13–S19, 1999

    Google Scholar 

  • DeVane CL, Ware MR, Emmanuel NP, Brawman-Mintzer O, Morton WA, Villarreal G & Lydiard RB. Evaluation of the efficacy, safety and physiological effects of fluvoxamine in social phobia. Int Clin Psychopharmacol 14, 345–351, 1999

    Article  PubMed  CAS  Google Scholar 

  • Di Paolo T. Modulation of brain dopamine transmission by sex steroids. Rev Neurosci 5, 27–42, 1994

    Article  PubMed  Google Scholar 

  • Drugan RC, Paul SM, Crawley JN. Decreased forebrain [35S]TBPS binding and increased [3H]muscimol binding in rats that do not develop stress-induced behavioral depression. Brain Res 631, 270–276, 1993

    Article  PubMed  CAS  Google Scholar 

  • Dummit ES III, Klein RG, Tancer NK, Asche B, Martin J & Fairbanks JA. Systematic assessment of 50 children with selective mutism. J Am Acad Child Adolesc Psychiatry 36 (5), 653–660, 1997

    Article  PubMed  Google Scholar 

  • Fahlen T, Nilsson HL, Borg K, Humble M & Pauli U. Social phobia: the clinical efficacy and tolerability of the monoamine oxidase -A and serotonin uptake inhibitor brofaromine. A double-blind placebo-controlled study. Acta Psychiatr Scand 92(5), 351–358, 1995

    Article  PubMed  CAS  Google Scholar 

  • Falloon I, Lloyd G-G & Harpin R-E. The treatment of social phobia: real-life rehearsal with non-professional therapists. J Nery Ment Dis 169, 180–184, 1981

    Article  CAS  Google Scholar 

  • Faravelli C, Guerrini Degl’Innocenti B & Giardinelli L. Epidemiology of anxiety disorders in Florence. Acta Psychiatr Scand 79, 308–312, 1989

    Article  CAS  Google Scholar 

  • Faravelli C, Zucchi T, Viviani B, Salmoria R, Perone A, Paionni A, Scarpato A, Vigliaturo D, Rosi S, D’Adamo D et al. Epidemiology of social phobia: a clinical approach. Eur Psychiatry 15, 17–24, 2000

    Article  PubMed  CAS  Google Scholar 

  • Faravelli C, Zucchi T, Viviani B, Salmoria R & Perone A. Epidemiology of social phobia: a clinical approach. Eur Psychiatry 15, 17–24, 2000

    Article  PubMed  CAS  Google Scholar 

  • Farde L, Gustaysson JP & Jönsson E. D2 dopamine receptors and personality traits. Nature 385, 590, 1997

    Article  PubMed  CAS  Google Scholar 

  • Fredrikson M, Annas P, Fischer H & Wik G. Gender and age differences in the prevalence of specific fears and phobias. Behav Res Ther 34, 33–39, 1996

    Article  PubMed  CAS  Google Scholar 

  • Fink G, Sumner BE, Rosie R, Grace O & Quinn JP. Estrogen control of central neurotransmission: effect on mood, mental state, and memory. Cell Mol Neurobiol 16(3), 325–344, 1996

    Article  PubMed  CAS  Google Scholar 

  • Frisch MB, Cornell J, Villanueva M & Retzlaff PJ. Clinical validation of the quality of life inventory: a measure of life satisfaction for use in treatment planning and outcome assessment. Psychol Assess 4, 92–101, 1992

    Article  Google Scholar 

  • Furmark T, Tillfors M, Everz PO, Marteinsdottir I, Gefvert 0 & Fredrikson M. Social phobia in the general population: prevalence and sociodemographic profile. Soc Psychiatry Psychiatr Epidemiol 34, 416–424, 1999

    Article  PubMed  CAS  Google Scholar 

  • Fyer AJ, Mannuzza S, Chapman TF, Lipsitz J, Martin LY & Klein DE Panic disorder and social phobia: effects of comorbidity on familial transmission. Anxiety 2 (4), 173–178, 1996

    Article  PubMed  CAS  Google Scholar 

  • Fyer A, Mannuzza S, Chapman T, Liebowitz M & Klein D. A direct interview family study of social phobia. Arch Gen Psychiatry 50, 286–293, 1993

    Article  PubMed  CAS  Google Scholar 

  • Gelernter CS, Uhde TW, Cimbolic P, Arnkoff DB, Vittone BJ, Tancer ME & Bartko JJ. Cognitive-behavioral and pharmacological treatments of social phobia. A controlled study. Arch Gen Psychiatry 48 (10), 938–945, 1991

    Article  PubMed  CAS  Google Scholar 

  • Gergel I, Pitts C, Oakes R & Kumar R. Significant improvement in symptoms of social phobia after paroxetine treatment. Biol Psychiatry 42, 26S, 1997

    Article  Google Scholar 

  • Godart NT, Flament MF, Lecrubier Y & Jeammet P. Anxiety disorders in anorexia nervosa: Co-morbidity and chronology of appearance. Eur Psychiatry 15, 38–45, 2000

    Article  PubMed  CAS  Google Scholar 

  • Häfner H, Riecher-Rössler A, An Der Heiden W, Maurer K, Faktenheuer B & Loffler W. Generating and testing a causal explanation of the gender difference in age at first onset of schizophrenia. Psychol Med 23, 925–940,1993

    Article  PubMed  Google Scholar 

  • Hazen AL & Stein MB. Clinical phenomenology and comorbidity. In: MB Stein (ed): Social phobia: clinical and research perspectives. Washington, DC: American Psychiatric Press, 1995

    Google Scholar 

  • Heimberg RG, Dodge CS, Hope DA, Kennedy CR, Zollo LJ & Becker RE. Cognitive behavioral group treatment for social phobia: Comparison with a credible placebo control. Cogn Ther Res 14 (1), 1–23, 1990

    Article  Google Scholar 

  • Heimberg RG, Holt CS, Schneier FR, Spitzer RL & Liebowitz MR. The issue of subtypes in the diagnosis of social phobia. J Anxiety Disord 7 (3), 249–269, 1993

    Article  Google Scholar 

  • Heimberg RG, Liebowitz MR, Hope DA, Schneier FR, Holt CS, Welkowitz LA, Juster HR, Campeas R, Bruch MA, Cloitre M et al. Cognitive behavioral group vs. therapy for social phobia. 12 week outcome. Arch Gen Psychiatry 55, 1133–1141, 1998

    Article  PubMed  CAS  Google Scholar 

  • Heimberg RG, Mueller GP, Holt CS, Hope DA & Liebowitz MR. Assessment of anxiety in social interaction and being observed by others: The social interaction and anxiety scale and the social phobia scale. Behav Ther 23, 53–73, 1992

    Article  Google Scholar 

  • Heimberg RG, Hope DA, Dodge CS & Becker RE. DSM-III-R Subtypes of social phobia: Comparison of generalized social phobics and public speaking phobics. J New Ment Dis 178 (3), 172–179, 1990

    Article  CAS  Google Scholar 

  • Heimberg RG, Homer KJ, Juster HR, Safren SA, Brown EJ, Schneier FR & Liebowitz MR. Psychometric properties of the Liebowitz social anxiety scale. Psychol Med 29, 199–212,1999

    Article  PubMed  CAS  Google Scholar 

  • Herbert JD, Bellack AS & Hope DA. Concurrent validity of the Social Phobia and Anxiety Inventory. J Psychopathol Behav Assess 13, 357–368, 1991

    Article  Google Scholar 

  • Herbert JD, Hope DA & Bellack AS. Validity of the distinction between generalized social phobia and avoidant personality disorder. J Abnorm Psychol 101, 332–339, 1992

    Article  PubMed  CAS  Google Scholar 

  • Hollander E, Kwon J, Weiller F, Cohen L, Stein DJ, DeCaria C, Liebowitz M & Simeon D. Serotonergic function in social phobia: comparison to normal control and obsessive-compulsive disorder subjects. Psychiatry Res 79, 213–217, 1998

    Article  PubMed  CAS  Google Scholar 

  • Holt CS, Heimberg RG & Hope DA. Avoidant personality disorder and the generalized subtype of social phobia. J Abnorm Psychol 101, 318–325, 1992

    Article  PubMed  CAS  Google Scholar 

  • Hunt C & Andrews G. Long-term outcome of panic disorder and social phobia. J Anxiety Disord 12 (4), 395–406, 1998

    Article  PubMed  CAS  Google Scholar 

  • Hutchings PS, Dutton MA. Symptom severity and diagnoses related to sexual assault history. J Anxiety Disord 11, 607–618, 1997

    Article  PubMed  CAS  Google Scholar 

  • Isaac M. Where are we going with SSRIs? Eur Neuropsychopharmacol 9 (3), S101–S106, 1999

    Article  PubMed  CAS  Google Scholar 

  • James IM, Griffith DN & Pearson RM et al. Effect of oxprenolol on stage-fright in musicians. Lancet ii, 952–954, 1977

    Google Scholar 

  • Johnson MR, Marazziti D, Brawman-Mintzer, Emmanuel NP, Ware MR, Morton A, Rossi A, Cassano GB & Lydiard BR. Abnormal peripheral benzodiazepines receptor density associated with generalized social phobia. Biol Psychiatry 43, 306–309, 1998

    Article  PubMed  CAS  Google Scholar 

  • Judd L. Social phobia: A clinical overview. J Clin Psychiatry 55 (6), 5–9, 1994

    PubMed  Google Scholar 

  • Kagan J, Reznick SJ & Snidman N. Biological bases of childhood shyness. Science 240,167–171, 1988

    Article  PubMed  CAS  Google Scholar 

  • Kelsey JE. Venlafaxine in social phobia. Psychopharmacol Bull 31, 767–771, 1995

    PubMed  CAS  Google Scholar 

  • Kendler KS, Neale MC, Kessler RC, Heath RC & Eves LJ. The genetic epidemiology of phobias in women. The interrelationship of agoraphobia, social phobia, situational phobia and simple phobia. Arch Gen Psychiatry 49, 273–281, 1992

    Article  PubMed  CAS  Google Scholar 

  • Kendler R, Neale M, Kessler R, Heath A & Eaves L. Major depression and phobias: The genetic and environmental sources of comorbidity. Psychol Med 23 (2), 361–371, 1993

    Article  PubMed  CAS  Google Scholar 

  • Kessler RC, Stang P, Wittchen HU, Stein M & Walters EE. Lifetime comorbidities between social phobia and mood disorders in the US National Comorbidity Survey. Psychol Med 29, 555–567, 1999

    Article  PubMed  CAS  Google Scholar 

  • Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen H-U & Kendler KS. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: Results from the National Comorbidity Survey. Arch Gen Psychiatry 51 (1), 8–19, 1994.

    Article  PubMed  CAS  Google Scholar 

  • Kessler RC, Stein MB & Berglund P. Social phobia subtypes in the National Comorbidity Survey. Am J Psychiatry 155, 613–619, 1998

    PubMed  CAS  Google Scholar 

  • Kobak KA, Schaettle SC, Greist JH, Jefferson JW, Katzelnick DJ & Dottl SL. Computer-administered rating scales for social anxiety in a clinical drug trial. Depress Anxiety 7, 97–104, 1998

    Article  PubMed  CAS  Google Scholar 

  • Kroboth PD & McAuley J. Progesterone: does it affect response to drug? Psychopharmacol Bull 33, 297–301, 1997

    PubMed  CAS  Google Scholar 

  • LaGreca AM, Dandes SK, Wick P, Shaw K & Stone WL. Development of the Social Anxiety Scale for Children: Reliability and concurrent validity. J Clin Child Psychol 17, 84–91, 1988

    Article  Google Scholar 

  • La Greca AM & Lopez N. Social anxiety among adolescents: Linkages with peer relations and friendships. J Abnorm Child Psychol 26 (2), 83–94, 1998

    Article  PubMed  Google Scholar 

  • Last CG, Strauss CC & Francis G. Comorbidity among childhood anxiety disorders. J Nery Ment Dis 175, 726–730, 1987

    Article  CAS  Google Scholar 

  • Lecrubier Y, Wittchen HU, Faravelli C, Bobes J, Patel A & Knapp M. A European perspective on social anxiety disorder. Eur Psychiatry 15, 5–16, 2000

    Article  PubMed  CAS  Google Scholar 

  • Lecrubier Y & Weiller E. Comorbidities in social phobia. Int Clin Psychopharmacol 12 (6), S17–S21, 1997

    Article  PubMed  Google Scholar 

  • Leon AC, Murzuk PM, Portera L. More reliable outcome measures can reduce sample size requirements. Arch Gen Psychiatry 52, 867–871, 1995

    Article  PubMed  CAS  Google Scholar 

  • Lesch PK, Bengel D, Heils S, Sabol SZ, Greenberg BG, Petri S, Benjamin J, Müller CR, Hamer DH & Murphy DL. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274, 1527–1531, 1996

    Article  PubMed  CAS  Google Scholar 

  • Liebowitz MR. Update on the diagnosis and treatment of social anxiety disorder. J Clin Psychiatry 60 (Suppl. 18), 22–26, 1996

    Google Scholar 

  • Liebowitz MR. Social phobia. Modern problems. Pharmacopsych 22, 141–173, 1987

    CAS  Google Scholar 

  • Liebowitz MR, Campeas R & Hollander E. Possible dopaminergic dysregulation in social phobia and atypical depression (Letter). Psychiatr Res 22, 89–90, 1987

    Article  CAS  Google Scholar 

  • Liebowitz JM, Schneier F, Campeas R, Hollander E, Hatterer J, Fyer A, Gorman JM, Papp L, Davies S, Gully R & Klein DE Phenelzine vs. atenolol in social phobia. A placebo-controlled comparison. Arch Gen Psychiatry 49, 290–300, 1992.

    PubMed  CAS  Google Scholar 

  • Lépine JP & Pélissolo A. Epidemiology and comorbidity of social anxiety disorder. In: HGM Westenberg & JA den Boer (eds): Focus on psychiatry. Social anxiety disorder. Amsterdam: Synthesis Publishers, 29–43, 1999

    Google Scholar 

  • Lépine JP & Lellouch J. Diagnosis and epidemiology of agoraphobia and social phobia. Clin Neuropharmacol 18, S15–S26, 1995

    Article  Google Scholar 

  • Levin AP, Schneier FR & Liebowitz MR. Social phobia: Biology and pharmacology. Clin Psychol Rev 9, 129–140, 1989

    Article  Google Scholar 

  • Liebowitz MR, Heimberg RG, Schneier FR, Hope DA, Davies S, Holt CS, Goetz D, Juster HR, Lin S-H, Bruch MA et al. Cognitive-behavioral group therapy versus phenelzine in social phobia: Long term outcome. Depress Anxiety 10 (3), 89–98, 1999

    Article  PubMed  CAS  Google Scholar 

  • Magee WJ, Eaton WW, Wittchen HU, McGoagle KA & Kessler RC. Agoraphobia, simple phobia and social phobia in the National Comorbidity Survey. Arch Gen Psychiatry 53, 159–168, 1996

    Article  PubMed  CAS  Google Scholar 

  • Majewska M. Neurosteroids: endogenous bimodal modulators of the GABA-A receptor mechanism of action and physiological significance. Prog Neurobiol 38, 379–395, 1992

    Article  PubMed  CAS  Google Scholar 

  • Majewska MD, Harrison NL, Schwartz RD, Barker JL & Paul SM. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science 232 (4753), 1004–1007,1986

    Article  PubMed  CAS  Google Scholar 

  • Mannuzza S, Schneier FR, Chapman TF, Liebowitz MR, Klein DF & Fyer AJ. Generalized social phobia. Reliability and validity. Arch Gen Psychiatry 52 (3), 230–237, 1995

    Article  PubMed  CAS  Google Scholar 

  • Mattick RP & Peter L. Treatment of severe social phobia: effects of guided exposure with or without cognitive restructuring. J Consult Clin Psychol 56, 251–260, 1988

    Article  PubMed  CAS  Google Scholar 

  • Mattick RP, Page A & Lampe L. Cognitive and behavioral aspects. In: MB Stein (ed): Social phobia: clinical and research perspectives. Washington, DC: American Psychiatric Press, 189–227, 1995

    Google Scholar 

  • Mattick RP, Peters L & Clarke JC. Exposure and cognitive restructuring for social phobia: controlled study. Behav Ther 20, 3–23, 1989

    Article  Google Scholar 

  • Mazzanti CM, Lappalainen J, Long JC, Bengel D, Naukkarinen H, Eggert M, Virkkunnen M, Linnoila M & Goldman D. Role of the serotonin transporter promoter polymorphism in anxiety-related traits. Arch Gen Psychiatry 55, 936–940, 1998

    Article  PubMed  CAS  Google Scholar 

  • McEwan KL & Devins GM. Is increased arousal in social anxiety noticed by others? J Abnorm Psychol 92, 417–421, 1983

    Article  PubMed  CAS  Google Scholar 

  • Mellings TMB & Alden LE. Cognitive processes in social anxiety: the effects of self-focus,rumination and anticipatory processing. Behav Res Ther 38, 243–257, 2000

    Article  PubMed  CAS  Google Scholar 

  • Merikangas KR & Angst J. Comorbidity and social phobia: evidence from clinical, epidemiologic, and genetic studies. Eur Arch Psychiatry Clin Neurosci 244, 297–303, 1995

    Article  PubMed  CAS  Google Scholar 

  • Mersch PPA. The treatment of social phobia: the differential effectiveness of exposure in vivo and an integration of exposure in vivo, rational emotive therapy and social skills training. Behav Res Ther 33, 259–269, 1995

    Article  PubMed  CAS  Google Scholar 

  • Millon T & Martinez A. Avoidant personality disorder: In: WJ Livesley (ed): The DSM-IV personality disorders. New York: Guildford Press, 218–233, 1995

    Google Scholar 

  • Montgomery SA. Implications of the severity of social phobia. J Affect Disord 50, S17–S22, 1998

    Article  PubMed  Google Scholar 

  • Montgomery SA. Social phobia: the need for treatment. Int Clin Psychopharmacol 12 (Suppl 6), S3–S9, 1997

    Article  PubMed  Google Scholar 

  • Newman MG, Hofmann SG, Trabert W, Roth WT & Taylor CB. Does behavioral treatment of social phobia lead to cognitive changes? Behav Ther 25, 503–517, 1994

    Article  Google Scholar 

  • Nutt D & Montgomery SA. Moclobemide in the treatment of social phobia. Int Clin Psy-chopharmacol 11 (Suppl 3), 77–82, 1996

    Article  Google Scholar 

  • Pande AC, Davidson JR, Jefferson JW, Janney CA, Katzelnick DJ, Weisler RH, Greist JH & Sutherland SM. Treatment of social phobia with gabapentin: A placebo-controlled study. J Clin Psychopharmacol 19 (4), 341–348, 1999

    Article  PubMed  CAS  Google Scholar 

  • Phillips RG & LeDoux JE. Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. Behav Neurosci 106, 274–285, 1992

    Article  PubMed  CAS  Google Scholar 

  • Pollack MH. Social anxiety disorder: Designing a pharmacologic treatment strategy. J Clin Psychiatry 60 (Suppl 9), 20–26, 1999

    PubMed  Google Scholar 

  • Prasko J, Kosova J, Paskova B, Praskova H, Klaschka J, Seifertova D & Sipek J. Pharmacotherapy and/or cognitive-behavioral therapy in the treatment of social phobia - Controlled study. Psychiatrie 3 (1), 13–18, 1999

    Google Scholar 

  • Price CJ & Friston KJ. Cognitive conjunction: a new approach to brain activation experiments. Neuroimaging 261–270, 1997

    Google Scholar 

  • Reich J, Goldenberg I, Nasile R, Goisman R & Keller M. A prospective follow-along study of the course of social phobia. Psychiatry Res 54, 249–258, 1994

    Article  PubMed  CAS  Google Scholar 

  • Reilly CE, Sokol L & Butler AC. A cognitive approach to understanding and treating anxiety. Hum Psychopharmacol Clin Exp 14, S16–S21, 1999

    Article  Google Scholar 

  • Richard IH, Schiffer RB & Kurlan R. Anxiety and Parkinson’s disease. J Neuropsychiatry Clin Neurosci 8 (4), 383–392, 1996

    PubMed  CAS  Google Scholar 

  • Ries BJ, McNeil DW, Boone ML, Turk CL, Carter LE & Heimberg RG. Assessment of con-temporary social phobia verbal report instruments. Behav Res Ther 36, 983–994, 1998

    Article  PubMed  CAS  Google Scholar 

  • Rubin KH, LeMare LJ & Lollis S. Social withdrawal in childhood: Developmental pathways to peer rejection. In: SR Asher & JD Coie (eds): Peer rejection in childhood. New York: Cambridge University Press, 1990

    Google Scholar 

  • Safren SA, Turk CL & Heimberg RG. Factor structure of the social interaction anxiety scale and the social phobia scale. Behav Res Ther 36, 443–453, 1998

    Article  PubMed  CAS  Google Scholar 

  • Safren SA, Heimberg RG, Horner KJ, Juster HR, Schneier FR & Liebowitz MR. Factor structure of social fears: The Liebowitz social anxiety scale. J Anxiety Disord 13 (3), 253–270, 1999

    Article  PubMed  CAS  Google Scholar 

  • Sanderson WC, Di Nardo PA, Rapee RM & Barlow DH. Syndrome comorbidity in patients diagnosed with a DSM-III-R anxiety disorder. J Abnorm Psychol 99, 308–312, 1990

    Article  PubMed  CAS  Google Scholar 

  • Schneier FR, Johnson J, Hornig CD, Liebowitz MR & Weissman MM. Social phobia: Comorbidity and morbidity in an epidemiologic sample. Arch Gen Psychiatry 49, 282–288, 1992

    Article  PubMed  CAS  Google Scholar 

  • Schneier FR, Heckelman LR, Garfinkel R, Campeas R, Fallon BA, Gitow A, Street L, Del Bene D & Liebowitz MR. Functional impairment in social phobia. J Clin Psychiatry 55 (8), 322–331, 1994

    PubMed  CAS  Google Scholar 

  • Schneier FR, Martin LY, Liebowitz MR, Gorman JM & Fyer AJ. Alcohol abuse in social phobia. J Anxiety Disord 3, 15–23, 1989

    Article  Google Scholar 

  • Schneier FR, Goetz D, Campeas R, Fallon B, Marshall R & Liebowitz MR. Placebo-con-trolled trial of moclobemide in social phobia. Br J Psychiatry 172, 70–77, 1998

    Article  PubMed  CAS  Google Scholar 

  • Scholing A & Emmelkamp PMG. Exposure with and without cognitive therapy for generalized social phobia: effects of individual and group treatment. Behav Res Ther 31, 667–681, 1993

    Article  PubMed  CAS  Google Scholar 

  • Shear MK & Beidel. Psychotherapy in the overall management strategy for social anxiety disorder. J Clin Psychiatry 59 (Suppl 17), 39–44, 1998

    PubMed  Google Scholar 

  • Simpson HB, Schneier FR, Campeas RB, Marshall RD, Fallon BA, Davies S, Klein DF & Liebowitz MR. Imipramine in the treatment of social phobia. J Clin Psychopharmacol 18 (2), 132–135, 1998

    Article  PubMed  CAS  Google Scholar 

  • Slaap BR, van Vliet IM, Westenberg HG & Den Boer JA. Responders and non-responders to drug treatment in social phobia: differences at baseline and prediction of response. J Affect Disord 39 (1), 13–19, 1996

    Article  PubMed  CAS  Google Scholar 

  • Stein DJ, Van der Linden G & Schmidt A. Social phobia when using a second language. South African Med J 88 (1), 61, 1998

    CAS  Google Scholar 

  • Stein DJ, Berk M, Els C, Emsley RA, Gittelson L, Wilson D, Oakes R & Hunter B. A double-blind placebo controlled trial of paroxetine in the management of social phobia (social anxiety disorder) in the South Africa. South African Med J 89, 402–406, 1999

    CAS  Google Scholar 

  • Stein MB. Phenomenology and epidemiology of social phobia. Int Clin Psychopharmacol 12 (Suppl) S23–S26, 1997

    Article  PubMed  Google Scholar 

  • Stein MB, Chartier MJ, Hazen AL, Kozak MV, Tancer ME, Lander S, Furer P, Chubaty D & Walker JR. A direct-interview family study of generalized social phobia. Am J Psychiatry 155 (1), 90–97, 1998

    PubMed  CAS  Google Scholar 

  • Stein MB, Fyer AJ, Davidson JRT, Pollack MH & Wiita B. Fluvoxamine treatment of social phobia (social anxiety disorder): A double-blind, placebo-controlled study. Am J Psychiatry 156, 756–760, 1999

    PubMed  CAS  Google Scholar 

  • Stein MB, Walker JR & Forde DR. Public speaking fears in a community sample: prevalence, impact on functioning, and diagnostic classification. Arch Gen Psychiatry 53, 169–174, 1996

    Article  PubMed  CAS  Google Scholar 

  • Stein MB, Liebowitz MR, Lydiard B, Pitts CD, Bushnell W & Gergel I. Paroxetine treatment of generalized social phobia (social anxiety disorder). A randomized controlled trial. JAMA 280, 708–713, 1998

    Article  PubMed  CAS  Google Scholar 

  • Stein MB, Tancer ME, Gelernter CS, Vittone BJ & Uhde TW. Major depression in patients with social phobia. Am J Psychiatry 147, 637–639, 1990

    PubMed  CAS  Google Scholar 

  • Stein MB, Heuser IJ, Juncos JL & Uhde TW. Anxiety disorders in patients with Parkinson’s disease. Am J Psychiatry 147, 217–220, 1990

    PubMed  CAS  Google Scholar 

  • Stein MB, Chartier MJ, Hazen AL, Kroft CD, Chale RA, Cote D & Walker JR. Paroxetine in the treatment of generalized social phobia: open-label treatment and double-blind, placebo-controlled discontinuation. J Clin Psychopharmacol 16, 218–222, 1996

    Article  PubMed  CAS  Google Scholar 

  • Stein MB, Chartier MJ, Hazen AL, Kozak M, Tancer ME, Lander S, Furer P, Chubaty D & Walker J. A family study of generalized social phobia. Am J Psychiatry 155, 90–97, 1998

    PubMed  CAS  Google Scholar 

  • Stopa L & Clark DM. Social phobia and interpretation of social events. Behav Res Ther 38, 273–283, 2000

    Article  PubMed  CAS  Google Scholar 

  • Stravynski A, Lelliott P, McNamee G et al. A typology of social phobia based on content of patients’complaints. 26th Congress of the European Association for Behaviour and Cognitive Therapy, Budapest, 2–5 October, 1996

    Google Scholar 

  • Taylor S, Woody S, Koch WJ, McLean P, Paterson RJ & Anderson KW. Cognitive restructuring in the treatment of social phobia. Efficacy and mode of action. Behav Modif 21 (4), 487–511, 1997

    Article  PubMed  CAS  Google Scholar 

  • Taylor S. Meta-analysis of cognitive-behavioral treatments for social phobia. J Behav Ther Exp Psychiatry, 27, 1–9, 1996

    Article  PubMed  CAS  Google Scholar 

  • Tiihonen J, Kuikka J, Bergstrom K, Lepola U, Koponen H & Leinonen E. Dopamine reuptake site densities in patients with social phobia. Am J Psychiatry 154 (2), 239–242, 1997

    PubMed  CAS  Google Scholar 

  • Torgersen S. The nature and origin of common phobic fears. Br J Psychiatry 134, 343–351, 1979

    Article  PubMed  CAS  Google Scholar 

  • Tupler LA, Davidson JRT, Smith RD, Lazeyras F, Charles HC & Krisnan KR. A repeat proton magnetic resonance spectroscopy study in social phobia. Biol Psychiatry 42, 419–424, 1997

    Article  PubMed  CAS  Google Scholar 

  • Turner SM, Beidel DC, Wolff PL, Spaulding S & Jacob RG. Clinical features affecting treatment outcome in social phobia. Behav Res The 34 (10), 795–804, 1996

    Article  CAS  Google Scholar 

  • Turner RM. The effects of personality disorder diagnosis on the outcome of social anxiety symptom reduction. J Pers Disord 1, 136–143, 1987

    Article  Google Scholar 

  • Turner AM, Beidel DC, Wolff PL et al. Clinical features affecting treatment outcome in social phobia. Behav Res Ther 34, 795–804, 1996

    Article  PubMed  CAS  Google Scholar 

  • Turner SM & Beidel DC. Social phobia: clinical syndrome, diagnosis, and comorbidity. Clin Psychol Rev 9, 3–18, 1989

    Article  Google Scholar 

  • Turner SM, Beidel DC & Jacob RG. Social phobia: a comparison of behaviour therapy and atenolol. J Consult Clin Psychol 62, 350–358, 1994

    Article  PubMed  CAS  Google Scholar 

  • Turner SM, Beidel DC & Dancu CV. Social phobia and anxiety Inventory Manual. North Tonawanda NY: MHS, 1995

    Google Scholar 

  • Turner SM, Beidel DC, Dancu CV & Keys DJ. Psychopathology of social phobia and comparison to avoidant personality disorder. J Abnorm Psychol 95, 389–394, 1986

    Article  PubMed  CAS  Google Scholar 

  • Turner SM, Beidel DC, Borden JW, Stanley MA & Jacob RG. Social phobia: Axis I and II cor-relates. J Abnorm Psychol 100, 102–106, 1991

    Article  PubMed  CAS  Google Scholar 

  • Turk C, Heimberg R, Orsillo SM, Holt CS, Gitow A, Street LL, Schneier FR & Liebowitz MR. An investigation of gender differences in social phobia. J Anxiety Disord 12 (3), 209–223, 1998

    Article  PubMed  CAS  Google Scholar 

  • Van Ameringen M, Mancini C & Oakman JM. Nefazodone in social phobia. J Clin Psychiatry 60 (2), 96–100, 1999

    Article  PubMed  Google Scholar 

  • Van Ameringen MA, Lane RM, Walker JR, Bowen RC, Chokka PR, Goldner EM, Johnston DG, Lavallee Y-J, Nanday S, Pecknold JC et al. Sertraline treatment of Generalized Social Phobia: A 20 week, double-blind, placebo-controlled study. Am J Psychiatry 158, 275–281, 2001

    Article  PubMed  Google Scholar 

  • Van Vliet IM, den Boer JA & Westenberg HGM. Psychopharmacological treatment of social phobia. Clinical and biochemical effects of brofaromine, a selective MAO-A inhibitor. Eur Neuropsychopharmacol 2, 21–29, 1992

    Article  PubMed  Google Scholar 

  • van Vliet IM, den Boer JA, Westenberg HG & Pian KL. Clinical effects of buspirone in social phobia: a double-blind placebo-controlled study. J Clin Psychiatry 58 (4), 164–168, 1997

    Article  PubMed  Google Scholar 

  • Van Vliet IM, den Boer JA & Westenberg HGM. Psychopharmacological treatment of social phobia: a double blind placebo controlled study with fluvoxamine. Psychopharmacol (Berl) 115, 128–134, 1994

    Article  Google Scholar 

  • Versiani M, Nardi AE, Mundim FD, Alves AB, Liebowitz MR & Amrein R. Pharmacotherapy of social phobia: a controlled study with moclobemide and phenelzine. Br J Psychiatry 161, 353–360, 1992

    Article  PubMed  CAS  Google Scholar 

  • Wacker HR, Müllejans R, Klein KH & Battegay R. Identification of cases of anxiety disorders and affective disorders in the community according to ICD-10 and DSM-IIIR by using the Composite International Diagnostic Interview (CIDI). Int J Meth Psychiatric Res 2, 91–100, 1992

    Google Scholar 

  • Walker JR, Van Ameringen MA, Swinson R, Bowen R, Chokka PR, Goldner E, Johnston DC, Lavallie YJ, Nandy S, Pecknold JC, Hadrava V & Lane RM. Prevention of relapse in generalized social phobia: Results of a 24-week study in responders to 20 weeks of sertraline treatment. J Clin Psychopharmacol 20 (5), 636–640, 2000

    Article  PubMed  CAS  Google Scholar 

  • Watson D & Friend R. Measurement of social-evaluative anxiety. J Cons Clin Psychol 33, 448–457, 1969

    Article  CAS  Google Scholar 

  • Weiller E, Bisserbe J-C, Boyer P, Lepine J-P & Lecrubier Y. Social phobia in general health care. An unrecognised undertreated disabling disorder. Br J Psychiatry 168, 169–174, 1996

    Article  PubMed  CAS  Google Scholar 

  • Weinstock LS. Gender differences in the presentation and management of social anxiety disorder. J Clin Psychiatry 60 (Suppl 9), 9–13, 1999

    PubMed  Google Scholar 

  • Weissman MM, Bland RC, Canino GJ, Greenwald S, Lee CK, Newman SC, Rubio-Stipec M & Wickramaratne PJ. The cross-national epidemiology of social phobia: a preliminary report. Int Clin Psychopharmacol. 11 (Suppl 3), 9–14, 1996

    Article  PubMed  Google Scholar 

  • Weiller E, Bisserbe J-C, Boyer P, Lepine J-P & Lecrubier Y. Social phobia in general health care: an unrecognised undertreated disabling disorder. Br J Psychiatry 168, 169–174, 1996

    Article  PubMed  CAS  Google Scholar 

  • Weizman R, Laor N, Karp L, Dagan E, Reiss A, Dar DE, Wolmer L & Gavish M. Alteration of platelet benzodiazepine receptors by stress of war. Am J Psychiatry 151 (5), 766–767, 1994

    PubMed  CAS  Google Scholar 

  • Westenberg HGM. Facing the challenge of social anxiety disorder. Eur Neuropsychopharmacol 9 (Suppl 3), S93–S99, 1999

    Article  PubMed  CAS  Google Scholar 

  • Widiger TA. Generalized social phobia versus avoidant personality disorder: a commentary on three studies. J Abnorm Psychol 101, 340–343, 1992

    Article  PubMed  CAS  Google Scholar 

  • Williams JMG, Mathews A & MacLeod C. The emotional Stroop task and psychopathology. Psychol Bull 120, 3–24, 1996

    Article  PubMed  CAS  Google Scholar 

  • Wittchen HU, Ahmoi Essau C, von Zerssen D, Krieg J-C & Zaudig M. Lifetime and six-month prevalence of mental disorders in the Munich follow-up study. Eur Arch Psychiatry Neurosci, 241–258, 1992

    Google Scholar 

  • Wittchen HU, Nelson CB & Lachner G. Prevalence of mental disorders and psychosocial impairments in adolescents and young adults. Psychol Med 28, 109–126, 1998

    Article  PubMed  CAS  Google Scholar 

  • Wittchen HU, Nelson CB & Kessler RC. Social fears and DSM-IV social phobia: prevalence,risk factors and comorbidity. Psychol Med 29, 309–329, 1999

    Article  PubMed  CAS  Google Scholar 

  • Wittchen HU, Feutsch M, Sonntag H, Muller N & Liebowitz M. Disability and quality of life in pure and comorbid social phobia: findings from a controlled study. Eur Psychiatry 15, 46–58, 2000

    Article  PubMed  CAS  Google Scholar 

  • Wittchen HU & Beloch E. The impact of social phobia on quality of life. Int Clin Psychopharmacol 11 (Suppl 3), 15–23, 1996

    Article  PubMed  Google Scholar 

  • Yao SN, Note I, Fanget F, Albuisson E, Bouvard M, Jalenques I & Cottraux J. Social anxiety in social phobics: Validation of Liebowitz’s social anxiety scale – French version. Encephale 25 (5), 429–435, 1999

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer Basel AG

About this chapter

Cite this chapter

Emilien, G., Dinan, T., Lepola, U.M., Durlach, C. (2002). Social phobia. In: Anxiety Disorders. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-8157-9_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-0348-8157-9_4

  • Publisher Name: Birkhäuser, Basel

  • Print ISBN: 978-3-0348-9460-9

  • Online ISBN: 978-3-0348-8157-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics